Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulrich Lehmann

Showing results (81-90 of 209) with videos related to

Pageof 21
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 12, 2017
Estrogen receptor (ESR1) mutation in bone metastases from breast cancerStephan Bartels, Matthias Christgen, Angelina Luft, et al.
Transplantation|December 1, 2007
Recipient-derived neoangiogenesis of arterioles and lymphatics in quilty lesions of cardiac allograftsDanny Jonigk, Ulrich Lehmann, Stephan Stuht, et al.
Virchows Archiv : an International Journal of Pathology|October 11, 2024
Diagnostic utility of ESR1 mutation detection in liquid biopsy of metastatic breast cancer patientsMaria Sandbothe, Britta Hasemeier, Elisa Schipper, et al.
Virchows Archiv : an International Journal of Pathology|August 11, 2018
Activating human epidermal growth factor receptor 2 (HER2) gene mutation in bone metastases from breast cancerMatthias Christgen, Stephan Bartels, Angelina Luft, et al.
International Journal of Cancer|August 21, 2008
KAI1/CD82 is a novel target of estrogen receptor-mediated gene repression and downregulated in primary human breast cancerMatthias Christgen, Henriette Bruchhardt, Matthias Ballmaier, et al.
European Journal of Haematology|January 18, 2021
Combination of myeloproliferative neoplasm driver gene activation with mutations of splice factor or epigenetic modifier genes increases risk of rapid blastic progressionStephan Bartels, Julia Vogtmann, Elisa Schipper, et al.
Cancer Treatment Reviews|November 20, 2023
Molecular profiling in cholangiocarcinoma: A practical guide to next-generation sequencingAlbrecht Stenzinger, Arndt Vogel, Ulrich Lehmann, et al.
Fetal and Pediatric Pathology|April 27, 2019
Discordancy for a Villous Maturation Defect in a Dizygotic Twin PlacentaHenning Feist, Corinna Brüschke, Ulrich Lehmann, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 21, 2009
Chemokine receptor CCR7 contributes to a rapid and efficient clearance of lytic murine gamma-herpes virus 68 from the lung, whereas bronchus-associated lymphoid tissue harbors virus during latencyJessica R Kocks, Heiko Adler, Heike Danzer, et al.
British Journal of Haematology|July 26, 2002
Reliability of lymphoma classification in bone marrow trephinesThomas Buhr, Florian Länger, Jerome Schlué, et al.
Pageof 21

Showing results (81-90 of 209) with videos related to

Sort By:
Pageof 21
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 12, 2017
Estrogen receptor (ESR1) mutation in bone metastases from breast cancerStephan Bartels, Matthias Christgen, Angelina Luft, et al.
Transplantation|December 1, 2007
Recipient-derived neoangiogenesis of arterioles and lymphatics in quilty lesions of cardiac allograftsDanny Jonigk, Ulrich Lehmann, Stephan Stuht, et al.
Virchows Archiv : an International Journal of Pathology|October 11, 2024
Diagnostic utility of ESR1 mutation detection in liquid biopsy of metastatic breast cancer patientsMaria Sandbothe, Britta Hasemeier, Elisa Schipper, et al.
Virchows Archiv : an International Journal of Pathology|August 11, 2018
Activating human epidermal growth factor receptor 2 (HER2) gene mutation in bone metastases from breast cancerMatthias Christgen, Stephan Bartels, Angelina Luft, et al.
International Journal of Cancer|August 21, 2008
KAI1/CD82 is a novel target of estrogen receptor-mediated gene repression and downregulated in primary human breast cancerMatthias Christgen, Henriette Bruchhardt, Matthias Ballmaier, et al.
European Journal of Haematology|January 18, 2021
Combination of myeloproliferative neoplasm driver gene activation with mutations of splice factor or epigenetic modifier genes increases risk of rapid blastic progressionStephan Bartels, Julia Vogtmann, Elisa Schipper, et al.
Cancer Treatment Reviews|November 20, 2023
Molecular profiling in cholangiocarcinoma: A practical guide to next-generation sequencingAlbrecht Stenzinger, Arndt Vogel, Ulrich Lehmann, et al.
Fetal and Pediatric Pathology|April 27, 2019
Discordancy for a Villous Maturation Defect in a Dizygotic Twin PlacentaHenning Feist, Corinna Brüschke, Ulrich Lehmann, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 21, 2009
Chemokine receptor CCR7 contributes to a rapid and efficient clearance of lytic murine gamma-herpes virus 68 from the lung, whereas bronchus-associated lymphoid tissue harbors virus during latencyJessica R Kocks, Heiko Adler, Heike Danzer, et al.
British Journal of Haematology|July 26, 2002
Reliability of lymphoma classification in bone marrow trephinesThomas Buhr, Florian Länger, Jerome Schlué, et al.
Pageof 21